Avian influenza A (H5N1) virus infection

References

Key articles

Centers for Disease Control and Prevention. Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease. May 2024 [internet publication].Full text

Centers for Disease Control and Prevention. Interim guidance on testing and specimen collection for patients with suspected infection with novel influenza A viruses with the potential to cause severe disease in humans. Jun 2023 [internet publication].Full text

World Health Organization. Guidelines for the clinical management of severe illness from influenza virus infections. Mar 2022 [internet publication].Full text

Centers for Disease Control and Prevention. Interim guidance on follow-up of close contacts of persons infected with novel influenza A viruses and use of antiviral medications for chemoprophylaxis. Mar 2022 [internet publication].Full text

Reference articles

1. Centers for Disease Control and Prevention. ​Technical report: highly pathogenic avian influenza A(H5N1) viruses. Dec 2023 [internet publication].Full text

2. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med. 2005 Jan 27;352(4):333-40.Full text  Abstract

3. Wang H, Feng Z, Shu Y, et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet. 2008 Apr 26;371(9622):1427-34. Abstract

4. Skowronski DM, Tweed SA, Petric M, et al. Human illness and isolation of low-pathogenicity avian influenza virus of the H7N3 subtype in British Columbia, Canada. J Infect Dis. 2006 Mar 15;193(6):899-900. Abstract

5. Peiris M, Yuen KY, Leung CW, et al. Human infection with influenza H9N2. Lancet. 1999 Sep 11;354(9182):916-7. Abstract

6. Uyeki TM, Chong YH, Katz JM, et al. Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China 1999. Emerg Infect Dis. 2002 Feb;8(2):154-9.Full text  Abstract

7. Eurosurveillance editorial team. Avian influenza A/(H7N2) outbreak in the United Kingdom. Euro Surveill. 2007 May 31;12(5):E070531.Full text  Abstract

8. Kurtz J, Manvell RJ, Banks J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet. 1996 Sep 28;348(9031):901-2. Abstract

9. Zhuang Y, Wang M, Liang L, et al. First known human death after infection with the avian influenza A/H3N8 virus: Guangdong Province, China, March 2023. Clin Infect Dis. 2024 Mar 20;78(3):646-50.Full text  Abstract

10. Qi X, Qiu H, Hao S, et al. Human infection with an avian-origin influenza A (H10N3) virus. N Engl J Med. 2022 Mar 17;386(11):1087-8.Full text  Abstract

11. Tong XC, Weng SS, Xue F, et al. First human infection by a novel avian influenza A(H7N4) virus. J Infect. 2018 Sep;77(3):249-57. Abstract

12. Tweed SA, Skowronski DM, David ST, et al. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis. 2004 Dec;10(12):2196-9.Full text  Abstract

13. Nguyen-Van-Tam JS, Nair P, Acheson P, et al. Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill. 2006 May 4;11(5):E060504.Full text  Abstract

14. Pan M, Gao R, Lv Q, et al. Human infection with a novel, highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings. J Infect. 2016 Jan;72(1):52-9. Abstract

15. Yang ZF, Mok CK, Peiris JS, et al. Human infection with a novel avian influenza A (H5N6) virus. N Engl J Med. 2015 Jul 30;373(5):487-9.Full text  Abstract

16. World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization H5N1 Evolution Working Group. Revised and updated nomenclature for highly pathogenic avian influenza A (H5N1) viruses. Influenza Other Respir Viruses. 2014 May;8(3):384-8.Full text  Abstract

17. World Health Organization. Evolution of the influenza A(H5) haemagglutinin: WHO/OIE/FAO H5 Working Group reports a new clade designated 2.3.4.4. Jan 2015 [internet publication].Full text

18. Smith GJ, Donis RO; World Health Organization/World Organisation for Animal Health/Food and Agriculture Organization (WHO/OIE/FAO) H5 Evolution Working Group. Nomenclature updates resulting from the evolution of avian influenza A(H5) virus clades 2.1.3.2a, 2.2.1, and 2.3.4 during 2013-2014. Influenza Other Respir Viruses. 2015 Sep;9(5):271-6.Full text  Abstract

19. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus; Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med. 2008 Jan 17;358(3):261-73.Full text  Abstract

20. World Health Organization. ​Genetic and antigenic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness. Feb 2023 [internet publication].Full text

21. World Health Organization. ​Assessment of risk associated with recent influenza A(H5N1) clade 2.3.4.4b viruses. Dec 2022 [internet publication].Full text

22. Centers for Disease Control and Prevention. ​H5N1 bird flu: current situation summary. May 2024 [internet publication].Full text

23. World Health Organization. Update on human cases of highly pathogenic avian influenza A(H5N1) virus infection, 2010. Wkly Epidemiol Rec. 2011 Apr 22;86(17):161-6.Full text  Abstract

24. Uyeki TM. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis. 2009 Jul 15;49(2):279-90.Full text  Abstract

25. de Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med. 2005 Feb 17;352(7):686-91.Full text  Abstract

26. Rajabali N, Lim T, Sokolowski C, et al. Avian influenza A (H5N1) infection with respiratory failure and meningoencephalitis in a Canadian traveller. Can J Infect Dis Med Microbiol. 2015 Jul-Aug;26(4):221-3.Full text  Abstract

27. Kandeel A, Manoncourt S, Abd el Kareem E, et al. Zoonotic transmission of avian influenza virus (H5N1), Egypt, 2006-2009. Emerg Infect Dis. 2010 Jul;16(7):1101-7.Full text  Abstract

28. International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B). Outbreak of mild respiratory disease caused by H5N1 and H9N2 infections among young children in Dhaka, Bangladesh, 2011. Health Sci Bulletin. 2011;9:1-12.Full text

29. Oner AF, Dogan N, Gasimov V, et al. H5N1 avian influenza in children. Clin Infect Dis. 2012 Jul;55(1):26-32.Full text  Abstract

30. Shinde V, Hanshaoworakul W, Simmerman JM, et al. A comparison of clinical and epidemiological characteristics of fatal human infections with H5N1 and human influenza viruses in Thailand, 2004-2006. PLoS One. 2011 Apr 29;6(4):e14809.Full text  Abstract

31. Chan PK. Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis. 2002 May 1;34(suppl 2):S58-64.Full text  Abstract

32. Peiris JS, Yu WC, Leung CW, et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet. 2004 Feb 21;363(9409):617-9.Full text  Abstract

33. World Health Organization. ​Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2024, 26 February 2024. Feb 2024 [internet publication].Full text

34. Centers for Disease Control and Prevention. Technical report: highly pathogenic avian influenza A(H5N1) viruses. Oct 2023 [internet publication].Full text

35. World Health Organization. ​Disease outbreak news: ​avian influenza A(H5N1) - United States of America. Apr 2024 [internet publication].Full text

36. Centers for Disease Control and Prevention. CDC reports second human case of H5 bird flu tied to dairy cow outbreak. May 2024 [internet publication].Full text

37. Centers for Disease Control and Prevention. Highly pathogenic avian influenza A(H5N1) virus in animals: interim recommendations for prevention, monitoring, and public health investigations. May 2024 [internet publication].Full text

38. Centers for Disease Control and Prevention. Interim guidance on the use of antiviral medications for treatment of human infections with novel influenza A viruses associated with severe human disease. May 2024 [internet publication].Full text

39. ​Centers for Disease Control and Prevention. Highly pathogenic avian influenza A (H5N1) virus infection reported in a person in the U.S. Apr 2024 [internet publication].Full text

40. Victorian Government Department of Health. Human case of avian influenza (bird flu) detected in returned traveller to Victoria. May 2024 [internet publication].Full text

41. World Health Organization. Disease outbreak news: avian influenza A(H5N1) - Viet Nam. Apr 2024 [internet publication].Full text

42. World Health Organization. ​Disease outbreak news: avian influenza A (H5N1) - Cambodia. Feb 2024 [internet publication].Full text

43. World Health Oragnization. ​Disease outbreak news: avian influenza A (H5N1) - Cambodia. Nov 2023 [internet publication].Full text

44. World Health Organization. ​Disease outbreak news: avian influenza A H5N1 - United Kingdom of Great Britain and Northern Ireland. May 2023 [internet publication].Full text

45. World Health Organization. ​Disease outbreak news: human infection caused by avian Influenza A (H5N1) - Chile. Apr 2023 [internet publication].Full text

46. Castillo A, Fasce R, Parra B, et al. The first case of human infection with H5N1 avian Influenza A virus in Chile. J Travel Med. 2023 Sep 5;30(5):taad083.Full text  Abstract

47. ​Centers for Disease Control and Prevention. Human infection with highly pathogenic avian influenza A(H5N1) virus in Chile. Apr 2023 [internet publication].Full text

48. World Health Organization. Disease outbreak news: avian influ​uenza A (H5N1) - Cambodia. Feb 2023 [internet publication].Full text

49. World Health Organization. Disease outbreak news: human infection caused by avian influenza A(H5) - Ecuador. Jan 2023 [internet publication].Full text

50. Bruno A, Alfaro-Núñez A, de Mora D, et al. First case of human infection with highly pathogenic H5 avian Influenza A virus in South America: A new zoonotic pandemic threat for 2023? J Travel Med. 2023 Sep 5;30(5):taad032.Full text  Abstract

51. World Health Organization. Update: WHO-confirmed human cases of avian influenza A (H5N1) infection, November 2003-May 2008. Wkly Epidemiol Rec. 2008 Nov 14;83(46):415-20. Abstract

52. Le MQ, Horby P, Fox A, et al. Subclinical avian influenza A(H5N1) virus infection in human, Vietnam. Emerg Infect Dis. 2013 Oct;19(10):1674-7.Full text  Abstract

53. Capelastegui F, Smith J, Kumbang J, et al. Pilot of asymptomatic swabbing of humans following exposures to confirmed avian influenza A(H5) in avian species in England, 2021/2022. Influenza Other Respir Viruses. 2023 Aug;17(8):e13187.Full text  Abstract

54. Aznar E, Casas I, González Praetorius A, et al. Influenza A(H5N1) detection in two asymptomatic poultry farm workers in Spain, September to October 2022: suspected environmental contamination. Euro Surveill. 2023 Feb;28(8):2300107.Full text  Abstract

55. Oliver I, Roberts J, Brown CS, et al. A case of avian influenza A(H5N1) in England, January 2022. Euro Surveill. 2022 Feb;27(5):2200061.Full text  Abstract

56. Qi Y, Ni HB, Chen X, et al. Seroprevalence of highly pathogenic avian influenza (H5N1) virus infection among humans in mainland China: a systematic review and meta-analysis. Transbound Emerg Dis. 2020 Sep;67(5):1861-71. Abstract

57. Gomaa MR, El Rifay AS, Abu Zeid D, et al. Incidence and seroprevalence of avian influenza in a cohort of backyard poultry growers, Egypt, Aug 2015-Mar 2019. Emerg Infect Dis. 2020 Sep;26(9):2129-36.Full text  Abstract

58. Tong S, Zhu X, Li Y, et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013;9(10):e1003657.Full text  Abstract

59. US Department of Agriculture Animal and Plant Health Inspection Service. Federal and state veterinary, public health agencies share update on HPAI detection in Kansas, Texas dairy herds. ​Mar 2024 [internet publication].Full text

60. Areechokchai D, Jiraphongsa C, Laosiritaworn Y, et al. Investigation of avian influenza (H5N1) outbreak in humans: Thailand, 2004. MMWR Morb Mortal Wkly Rep. 2006 Apr 28;55(1):3-6.Full text  Abstract

61. Dinh PN, Long HT, Tien NT, et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis. 2006 Dec;12(12):1841-7.Full text  Abstract

62. World Health Organization. Update on human cases of highly pathogenic avian influenza A(H5N1) virus infection, 2011. Wkly Epidemiol Rec. 2012 Mar 30;87(13):117-23.Full text  Abstract

63. Mounts AW, Kwong H, Izurieta HS, et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis. 1999 Aug;180(2):505-8. Abstract

64. Zhou L, Liao Q, Dong L, et al. Risk factors for human illness with avian influenza A (H5N1) virus infection in China. J Infect Dis. 2009 Jun 15;199(12):1726-34.Full text  Abstract

65. Wan XF, Dong L, Lan Y, et al. Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China. J Virol. 2011 Dec;85(24):13432-8.Full text  Abstract

66. Cavailler P, Chu S, Ly S, et al. Seroprevalence of anti-H5 antibody in rural Cambodia, 2007. J Clin Virol. J Clin Virol. 2010 Jun;48(2):123-6. Abstract

67. Kandun IN, Tresnaningsih E, Purba WH, et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet. 2008 Aug 30;372(9640):744-9. Abstract

68. Horby P, Sudoyo H, Viprakasit V, et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect. 2010 Nov;138(11):1550-8.Full text  Abstract

69. Human cases of avian influenza A (H5N1) in North-West Frontier Province, Pakistan, October-November 2007. Wkly Epidemiol Rec. 2008 Oct 3;83(40):359-64. Abstract

70. Aditama TY, Samaan G, Kusriastuti R, et al. Risk factors for cluster outbreaks of avian influenza A H5N1 infection, Indonesia. Clin Infect Dis. 2011 Dec;53(12):1237-44.Full text  Abstract

71. Aditama TY, Samaan G, Kusriastuti R, et al. Avian influenza H5N1 transmission in households, Indonesia. PLoS One. 2012;7(1):e29971.Full text  Abstract

72. Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med. 2006 Nov 23;355(21):2186-94.Full text  Abstract

73. Beigel JH, Farrar J, Han AM, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005 Sep 29;353(13):1374-85.Full text  Abstract

74. Centers for Disease Control and Prevention. Current H5N1 bird flu situation in dairy cows. May 2024 [internet publication].Full text

75. Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature. 2012 May 2;486(7403):420-8.Full text  Abstract

76. Neumann G, Macken CA, Karasin AI, et al. Egyptian H5N1 influenza viruses-cause for concern? PLoS Pathog. 2012;8(11):e1002932.Full text  Abstract

77. Russell CA, Fonville JM, Brown AE, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science. 2012 Jun 22;336(6088):1541-7.Full text  Abstract

78. Uyeki TM, Bresee JS. Detecting human-to-human transmission of avian influenza A (H5N1). Emerg Infect Dis. 2007 Dec;13(12):1969-71.Full text  Abstract

79. Refaey S, Azziz-Baumgartner E, Amin MM, et al. Increased number of human cases of influenza virus A(H5N1) infection, Egypt, 2014-15. Emerg Infect Dis. 2015 Dec;21(12):2171-3.Full text  Abstract

80. Garten RJ, Davis CT, Russell CA, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009 Jul 10;325(5937):197-201.Full text  Abstract

81. Horimoto T, Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol. 2005 Aug;3(8):591-600. Abstract

82. Yamada S, Suzuki Y, Suzuki T, et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature. 2006 Nov 16;444(7117):378-82. Abstract

83. van Riel D, Munster VJ, de Wit E, et al. H5N1 virus attachment to lower respiratory tract. Science. 2006 Apr 21;312(5772):399. Abstract

84. Shu Y, Li CK, Li Z, et al. Avian influenza A(H5N1) viruses can directly infect and replicate in human gut tissues. J Infect Dis. 2010;201:1173-1177. Abstract

85. Chandrasekaran A, Srinivasan A, Raman R, et al. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol. 2008 Jan;26(1):107-13. Abstract

86. Auewarakul P, Suptawiwat O, Kongchanagul A, et al. An avian influenza H5N1 virus that binds to a human-type receptor. J Virol. 2007 Sep;81(18):9950-5.Full text  Abstract

87. Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res. 2005 Nov 11;6(1):135.Full text  Abstract

88. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006 Oct;12(10):1203-7.Full text  Abstract

89. Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet. 2007 Sep 29;370(9593):1137-45. Abstract

90. Apisarnthanarak A, Erb S, Stephenson I, et al. Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center. Clin Infect Dis. 2005 Jan 15;40(2):e16-8. Abstract

91. Liem NT, Lim W. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg Infect Dis. 2005 Feb;11(2):210-5.Full text  Abstract

92. Schultsz C, Dong VC, Chau NV, et al. Avian influenza H5N1 and healthcare workers. Emerg Infect Dis. 2005 Jul;11(7):1158-9.Full text  Abstract

93. Ortiz JR, Katz MA, Mahmoud MN, et al. Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. J Infect Dis. 2007 Dec 1;196(11):1685-91.Full text  Abstract

94. UK Health Security Agency. Management of contacts of highly pathogenic avian influenza H5N1 during the 2023 to 2024 avian influenza season. Feb 2024 [internet publication].Full text

95. Prieto-Lara E, Llanos-Mendez A. Safety and immunogenicity of prepandemic H5N1 influenza vaccines: a systematic review of the literature. Vaccine. 2010 Jun 11;28(26):4328-34. Abstract

96. Vesikari T, Forstén A, Herbinger KH, et al. Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly. Vaccine. 2012 Feb 8;30(7):1388-96. Abstract

97. Langley JM, Risi G, Caldwell M, et al. Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study. J Infect Dis. 2011 Jun 15;203(12):1729-38.Full text  Abstract

98. US Food and Drug Administration. Influenza virus vaccine, H5N1 (for national stockpile). Feb 2018 [internet publication].Full text

99. Qualls N, Levitt A, Kanade N, et al; CDC Community Mitigation Guidelines Work Group. Community mitigation guidelines to prevent pandemic influenza - United States, 2017. MMWR Recomm Rep. 2017 Apr 21;66(1):1-34.Full text  Abstract

100. Centers for Disease Control and Prevention. Case definitions for investigations of human infection with avian influenza A viruses in the United States. Mar 2022 [internet publication].Full text

101. World Health Organization. Interim guidelines for avian influenza case management. Sep 2007 [internet publication].Full text

102. Centers for Disease Control and Prevention. Interim guidance on testing and specimen collection for patients with suspected infection with novel influenza A viruses with the potential to cause severe disease in humans. Jun 2023 [internet publication].Full text

103. ​European Centre for Disease Prevention and Control. Enhanced surveillance of severe avian influenza virus infections in hospital settings in the EU/EEA. Jun 2023 [internet publication].Full text

104. Centers for Disease Control and Prevention. Interim guidance for infection control within healthcare settings when caring for confirmed cases, probable cases, and cases under investigation for infection with novel influenza A viruses associated with severe disease. Mar 2022 [internet publication].Full text

105. World Health Organization. Collecting, preserving and shipping specimens for the diagnosis of avian influenza A(H5N1) virus infection. Oct 2006 [internet publication].Full text

106. UK Health Security Agency. Laboratory investigations for suspected avian influenza A(H7) and A(H5) human infections in England. 2022 [internet publication].Full text

107. World Health Organization. Guidelines for the clinical management of severe illness from influenza virus infections. Mar 2022 [internet publication].Full text

108. American Academy of Pediatrics. Respiratory syncytial virus. In: Pickering LK, ed. Red book: 2006 report of the Committee on Infectious Diseases, 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006:561.

109. UK Health Security Agency. Avian influenza: guidance for managing human cases. Feb 2024 [internet publication].Full text

110. Centers for Disease Control and Prevention. Interim guidance on follow-up of close contacts of persons infected with novel influenza A viruses and use of antiviral medications for chemoprophylaxis. Mar 2022 [internet publication].Full text

111. Centers for Disease Control and Prevention. Interim guidance on influenza antiviral chemoprophylaxis of persons exposed to birds with avian influenza A viruses associated with severe human disease or with the potential to cause severe human disease. Mar 2022 [internet publication].Full text

112. Patel RB, Mathur MB, Gould M, et al. Demographic and clinical predictors of mortality from highly pathogenic avian influenza A (H5N1) virus infection: CART analysis of international cases. PLoS One. 2014 Mar 25;9(3):e91630.Full text  Abstract

113. Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Dec 2023 [internet publication].Full text

114. Adisasmito W, Chan PK, Lee N, et al. Effectiveness of antiviral treatment in human influenza A (H5N1) infections: analysis of a Global Patient Registry. J Infect Dis. 2010 Oct 15;202(8):1154-60.Full text  Abstract

115. Chan PK, Lee N, Zaman M, et al. Determinants of antiviral effectiveness in influenza virus A subtype H5N1. J Infect Dis. 2012 Nov;206(9):1359-66. Abstract

116. Duval X, van der Werf S, Blanchon T, et al. Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial. PLoS Med. 2010 Nov 2;7(11):e1000362.Full text  Abstract

117. Kayali G, Webby RJ, Ducatez MF, et al. The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in Egypt. PLoS One. 2011 Mar 21;6(3):e17730.Full text  Abstract

118. Fiebig L, Soyka J, Buda S, et al. Avian influenza A(H5N1) in humans: new insights from a line list of World Health Organization confirmed cases, September 2006 to August 2010. Euro Surveill. 2011 Aug 11;16(32):19941.Full text  Abstract

119. Arabi Y, Gomersall CD, Ahmed QA, et al. The critically ill avian influenza A (H5N1) patient. Crit Care Med. 2007 May;35(5):1397-403. Abstract

120. de Jong MD, Tran TT, Truong HK, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. 2005;353:2667-2672.Full text  Abstract

121. Le QM, Kiso M, Someya K, et al. Avian flu: isolation of drug-resistant H5N1 virus. Nature. 2005 Oct 20;437(7062):1108. Abstract

122. Le MT, Wertheim HF, Nguyen HD, et al. Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam. PLoS One. 2008 Oct 6;3(10):e3339.Full text  Abstract

123. Taylor WR, Thinh BN, Anh GT, et al. Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza. PLoS One. 2008;3(10):e3410.Full text  Abstract

124. Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med. 2007 Oct 4;357(14):1450-1.Full text  Abstract

125. Yu H, Gao Z, Feng Z, et al. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One. 2008 Aug 21;3(8):e2985.Full text  Abstract

126. Centers for Disease Control and Prevention. CDC Yellow Book 2024: health information for international travel​. Section 5: travel-associated infections & diseases - influenza. May 2023 [internet publication].Full text

127. World Health Organization. Zoonotic influenza A virus outbreak toolbox. Sep 2022 [internet publication].Full text

128. Australian Government Department of Health and Aged Care. Avian influenza in humans (bird flu). ​May 2024 [internet publication].Full text

129. UK Health Security Agency. Avian influenza: guidance, data and analysis. Jun 2023 [internet publication].Full text

130. Lee CM, Hudson LD. Long-term outcomes after ARDS. Semin Respir Crit Care Med. 2001 Jun;22(3):327-36. Abstract

131. Ehlenbach WJ, Hough CL, Crane PK, et al. Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA. 2010 Feb 24;303(8):763-70.Full text  Abstract

Use of this content is subject to our disclaimer